Genetic screening in Parkinson*s disease patients to identify GBA1 mutation carriers for future clinical trials.
- Conditions
- Parkinson's disease10028037
- Registration Number
- NL-OMON56348
- Lead Sponsor
- Vanqua Bio Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 1000
Inclusion Criteria
1. Age 40-80 years of age at screening (inclusive).
2. All participants must understand and provide written informed consent prior
to any study-specific procedures
3. Able to speak, read, and understand study procedures in Dutch sufficiently
to allow completion of all study assessments.
4. Patient-reported clinical diagnosis of Parkinson*s disease by a neurologist
within the last 10 years.
Exclusion Criteria
1. Known non-GBA-1 mutation for Parkinson*s disease
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method